Pro Medicus Zukünftiges Wachstum
Future Kriterienprüfungen 5/6
Pro Medicus wird ein jährliches Gewinn- und Umsatzwachstum von 20.5% bzw. 18.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 20.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 45.3% betragen.
Wichtige Informationen
21.1%
Wachstumsrate der Gewinne
21.3%
EPS-Wachstumsrate
| Healthcare Services Gewinnwachstum | 24.6% |
| Wachstumsrate der Einnahmen | 18.8% |
| Zukünftige Eigenkapitalrendite | 45.7% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 28 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?
May 02
Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Dec 10Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Oct 09Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention
Aug 12Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jul 08Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
May 09Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Apr 02Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital
Jan 25We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Dec 13Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
Oct 26Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Sep 14Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Jul 06Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jun 15Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Mar 16Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Feb 23Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Oct 26Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively
Aug 13Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Jul 26Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency
May 07Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 15This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)
Feb 20Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Feb 18
Is Pro Medicus (ASX:PME) The Next Multi-Bagger?
Feb 01How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?
Jan 12Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?
Dec 28Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment
Dec 11Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?
Nov 26Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?
Aug 09What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?
Aug 09Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?
Jul 21How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?
Jul 03Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2026 | 255 | 134 | 121 | 131 | 13 |
| 6/30/2025 | 207 | 105 | 96 | 104 | 13 |
| 6/30/2024 | 162 | 80 | 75 | 79 | 13 |
| 12/31/2023 | 142 | 70 | 65 | 71 | N/A |
| 9/30/2023 | 134 | 65 | 60 | 67 | N/A |
| 6/30/2023 | 125 | 61 | 56 | 63 | N/A |
| 3/31/2023 | 115 | 56 | 51 | 59 | N/A |
| 12/31/2022 | 106 | 51 | 47 | 55 | N/A |
| 9/30/2022 | 100 | 48 | 50 | 58 | N/A |
| 6/30/2022 | 93 | 44 | 53 | 62 | N/A |
| 3/31/2022 | 87 | 41 | 47 | 55 | N/A |
| 12/31/2021 | 81 | 38 | 41 | 49 | N/A |
| 9/30/2021 | 74 | 34 | 36 | 44 | N/A |
| 6/30/2021 | 68 | 31 | 31 | 39 | N/A |
| 3/31/2021 | 64 | 28 | 27 | 36 | N/A |
| 12/31/2020 | 59 | 25 | 24 | 32 | N/A |
| 9/30/2020 | 58 | 24 | 24 | 32 | N/A |
| 6/30/2020 | 57 | 23 | 24 | 31 | N/A |
| 3/31/2020 | 55 | 23 | 25 | 33 | N/A |
| 12/31/2019 | 54 | 22 | 27 | 34 | N/A |
| 9/30/2019 | 52 | 21 | 22 | 30 | N/A |
| 6/30/2019 | 50 | 19 | 17 | 25 | N/A |
| 3/31/2019 | 47 | 17 | N/A | N/A | N/A |
| 12/31/2018 | 43 | 16 | 7 | 14 | N/A |
| 9/30/2018 | 39 | 13 | 7 | 14 | N/A |
| 6/30/2018 | 34 | 10 | 7 | 14 | N/A |
| 3/31/2018 | 33 | 9 | N/A | N/A | N/A |
| 12/31/2017 | 32 | 8 | 8 | 15 | N/A |
| 9/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 6/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 3/31/2017 | 30 | 9 | N/A | 13 | N/A |
| 12/31/2016 | 28 | 8 | N/A | 12 | N/A |
| 9/30/2016 | 28 | 7 | N/A | 11 | N/A |
| 6/30/2016 | 28 | 6 | N/A | 11 | N/A |
| 3/31/2016 | 25 | 5 | N/A | 9 | N/A |
| 12/31/2015 | 23 | 5 | N/A | 8 | N/A |
| 9/30/2015 | 20 | 4 | N/A | 6 | N/A |
| 6/30/2015 | 17 | 3 | N/A | 4 | N/A |
| 3/31/2015 | 17 | 3 | N/A | 4 | N/A |
| 12/31/2014 | 17 | 3 | N/A | 4 | N/A |
| 9/30/2014 | 16 | 2 | N/A | 4 | N/A |
| 6/30/2014 | 14 | 2 | N/A | 4 | N/A |
| 12/31/2013 | 11 | 1 | N/A | 6 | N/A |
| 9/30/2013 | 11 | -1 | N/A | 5 | N/A |
| 6/30/2013 | 11 | -3 | N/A | 4 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PMEDas prognostizierte Gewinnwachstum (20.3% pro Jahr) liegt über der Sparquote (2.3%).
Ertrag vs. Markt: PMEDie Erträge des Unternehmens (20.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (13.6% pro Jahr).
Hohe Wachstumserträge: PMEEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: PMEDie Einnahmen des Unternehmens (18% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (4.9% pro Jahr).
Hohe Wachstumseinnahmen: PMEDie Einnahmen des Unternehmens (18% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: PMEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (45.3%).